Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice.
Level 5 - mechanism / opinion, no new human data
Preclinical animal study with no human data.
PubMed 33796866 · doi:10.1038/s43587-020-00006-2
What was done
Researchers tested the effects of restricting dietary branched-chain amino acids (BCAAs: leucine, isoleucine, and valine) in mice. The intervention was evaluated in two progeroid mouse models, in wild-type C57BL/6J mice beginning in midlife, and as a lifelong feeding regimen in wild-type mice. Outcomes assessed were survival, lifespan, frailty, and metabolic health parameters.
What was found
Lifelong BCAA restriction resulted in a 30% increase in lifespan and reduced frailty in male wild-type mice, but had no lifespan benefit in female wild-type mice. Midlife-initiated BCAA restriction delayed frailty and promoted metabolic health in wild-type C57BL/6J mice. BCAA restriction also increased survival in two progeroid mouse models. Specific numeric values for sample sizes, survival times, and metabolic indices were not provided in the abstract.
Why it matters
This study indicates that restricting specific branched-chain amino acids mimics key longevity and metabolic benefits of protein restriction in mice. It highlights nutrient quality rather than gross protein quantity as a driver of healthy aging pathways.
Limits
All findings are from rodent models, so direct clinical relevance to humans remains unproven. Lifespan extension was strictly sex-specific (observed only in males). The abstract provides no exact sample sizes (n), dosing details, or numeric values for the progeroid survival outcomes.
Cited by
- supports Animal studies show that feeding higher amounts of branched-chain amino acids results in shorter lifespan compared to lower amounts.